Therapeutic potential of herbal drugs in cerebral ischemia

Indian Journal of Physiology and Pharmacology

Volumn 54, Issue 2, 2010, Pages 99-122

  Gupta, Y K ^a   Briyal, Seema ^b   Gulati, Anil ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Cerebral ischemia; Herbal drugs; Stroke

Indexed keywords

CARDIOVASCULAR AGENT; FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT; PLANT MEDICINAL PRODUCT;

ANIMAL; BRAIN ISCHEMIA; DRUG COMBINATION; EVIDENCE BASED MEDICINE; HUMAN; PATHOPHYSIOLOGY; PHYTOTHERAPY; REVIEW; STROKE; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; CARDIOVASCULAR AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT PREPARATIONS; STROKE; TREATMENT OUTCOME;

EID: 79952112971     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. Gutierrez M, Diez Tejedor E, Alonso de Lecinana M, Fuentes B, Carceller F, Roda JM. Thrombolysis and neuroprotection in cerebral ischemia. Cerebrovasc Dis 2006; 21 Suppl 2: 118-126.
2. Scott JF, Gray CS. Cerebral and systemic pathophysiological responses to acute stroke. Age Ageing 2000; 29: 197-202.
3. Durukan A, Strbian D, Tatlisumak T. Rodent models of ischemic stroke: a useful tool for stroke drug development. Curr Pharm Des 2008; 14: 359-370.
4. Martinez-Vila E, Sieira PI. Current status and perspectives of neuroprotection in ischemic stroke treatment. Cerebrovasc Dis 2001; 11 Suppl 1: 60-70.
5. Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther 2009; 7: 375-387.
6. Shaw GJ, Meunier JM, Huang SL, Lindsell CJ, McPherson DD, Holland CK. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb Res 2009; 124: 306-310.
7. Legos JJ, Tuma RF, Barone FC. Pharmacological interventions for stroke: failures and future. Expert Opin Investig Drugs 2002; 11: 603-614.
8. Green AR. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br J Pharmacol 2008; 153 Suppl 1: S325-S338.
9. Fisher M, Schaebitz W. An overview of acute stroke therapy: past, present, and future. Arch Intern Med 2000; 160: 3196-3206.
10. Jonas S. Prophylactic pharmacologic neuroprotection against focal cerebral ischemia. Ann N Y Acad Sci 1995; 765: 21-5; Discussion 6-7.
11. Chaudhary G, Sharma U, Jagannathan NR, Gupta YK. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 2003; 30: 399-404.
12. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371(9624): 1612-1623.
13. Stroke units seem to have a long term impact on patients' outcomes. BMJ 2000; 320(7234): E.
14. Grotta J, Marler J. Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol 2007; 68 Suppl 1: S12-S16.
15. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337-354.
16. Gupta YK, Briyal S. Animal models of cerebral ischemia for evaluation of drugs. Indian J Physiol Pharmacol 2004; 48: 379-394.
17. Del Zoppo GJ. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J Intern Med 1995; 237: 79-88.
18. Dorman PJ, Sandercock PA. Considerations in the design of clinical trials of neuroprotective therapy in acute stroke. Stroke 1996; 27: 1507-1515.
19. Boltze J, Forschler A, Nitzsche B, Waldmin D, Hoffmann A, Boltze CM, et al. Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 1951-1264.
20. Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol 2007; 61: 396-402.
21. Liebeskind DS, Kasner SE. Neuroprotection for ischaemic stroke: an unattainable goal? CNS Drugs 2001; 15: 165-174.
22. Jonas S, Aiyagari V, Vieira D, Figueroa M. The failure of neuronal protective agents versus the success of thrombolysis in the treatment of ischemic stroke. The predictive value of animal models. Ann N Y Acad Sci 2001; 939: 257-267.
23. Drummond JC, Piyash PM, Kimbro JR. Neuroprotection failure in stroke. Lancet 2000; 356(9234): 1032-1033.
24. Tamam Y, Tasdemir N, Toprak R, Tamam B, Iltumur K. Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome. Int J Neurosci 2009; 119: 919-935.
25. Kaste M. Thrombolysis in ischaemic stroke-present and future: role of combined therapy. Cerebrovasc Dis 2001; 11 Suppl 1: 55-59.
26. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke 2003; 34: 359-361.
27. Sinha K, Degaonkar MN, Jagannathan NR, Gupta YK. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001; 428: 185-192.
28. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002; 71: 655-665.
29. Gupta YK, Sinha K, Chaudhary G, Jagannathan NR. Protective effect of adenosine against neuronal injury induced by middle cerebral artery occlusion in rats as evidenced by diffusion-weighted imaging. Pharmacol Biochem Behav 2002; 72: 569-574.
30. Chaudhary G, Sinha K, Gupta YK. Protective effect of exogenous administration of alpha-tocopherol in middle cerebral artery occlusion model of cerebral ischemia in rats. Fundam Clin Pharmacol 2003; 17: 703-707.
31. Gupta YK, Briyal S, Sharma U, Jagannathan NR, Gulati A. Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats. Life Sci 2005; 77: 15-27.
32. Briyal S, Pant AB, Gupta YK. Protective effect of endothelin antagonist (TAK-044) on neuronal cell viability in in vitro oxygen-glucose deprivation model of stroke. Indian J Physiol Pharmacol 2006; 50: 157-162.
33. Lindsberg PJ, Roine RO, Tatlisumak T, Sairanen T, Kaste M. The future of stroke treatment. Neurol Clin 2000; 18: 495-510.
34. Spinnewyn B, Cornet S, Auguet M, Chabrier PE. Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia. J Cereb Blood Flow Metab 1999; 19: 139-143.
35. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 2000; 39: 881-888.
36. Lyden PD, Jackson-Friedman C, Shin C, Hassid S. Synergistic combinatorial stroke therapy: A quantal bioassay of a GABA agonist and a glutamate antagonist. Exp Neurol 2000; 163: 477-489.
37. Gupta YK, Chaudhary G, Sinha K. Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat. Can J Physiol Pharmacol 2002; 80: 210-217.
38. Briyal S, Gulati A, Gupta YK. Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats. Methods Find Exp Clin Pharmacol 2007; 29: 257-263.
39. Fisher M, Jonas S, Sacco RL, Jones S. Prophylactic neuroprotection for cerebral ischemia. Stroke 1994; 25: 1075-1080.
40. Prabhakar S, Das CP. Ischaemic stroke: new frontiers. Neurol India 1999; 47: 168-177.
41. Qian XP, Xu F, Song JL, Zhao JH. [Influence of different fr equencies of acupuncture on therapeutic effect in patients with cerebral infarction at convalescence]. Zhongguo Zhen Jiu 2009; 29: 7-9.
42. Chen C, Venketasubramanian N, Gan RN, Lambert C, Picard D, Chan BP, et al. Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery. Stroke 2009; 40: 859-863.
43. Tang MK, Ren DC, Zhang JT, Du GH. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002; 9: 405-409.
44. Kuang P, Tao Y, Tian Y. Radix Salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury. J Tradit Chin Med 1996; 16: 138-142.
45. Sun M, Zhang JJ, Shan JZ, Zhang H, Jin CY, Xu S, et al. Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma. Phytomedicine 2009; 16: 683-689.
46. O'Brien KA, Ling S, Abbas E, Dai A, Zhang J, Wang WC, et al. A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules. Evid Based Complement Alternat Med 2008.
47. Liao SL, Kao TK, Chen WY, Lin YS, Chen SY, Raung SL, et al. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett 2004; 372: 40-45.
48. Luo XX, Ogata H, Xu X, Ishitobi F. [Protective effect of tetramethylpyrazine on ischemic neuronal damage in the gerbil hippocampus]. No To Shinkei 1994; 46: 841-846.
49. Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, et al. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett 2009; 449: 24-27.
50. Hsiao G, Chen YC, Lin JH, Lin KH, Chou DS, Lin CH, et al. Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats. Planta Med 2006; 72: 411-417.
51. Ye R, Li N, Han J, Kong X, Cao R, Rao Z, et al. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 2009; 64: 306-310.
52. Son HY, Han HS, Jung HW, Park YK. Panax notoginseng Attenuates the Infarct Volume in Rat Ischemic Brain and the Inflammatory Response of Microglia. J Pharmacol Sci 2009; 109: 368-379.
53. Kim YO, Kim HJ, Kim GS, Park HG, Lim SJ, Seong NS, et al. Panax ginseng protects against global ischemia injury in rat hippocampus. J Med Food 2009; 12: 71-76.
54. Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008; 14: 715-721.
55. Yoshikawa T, Akiyoshi Y, Susumu T, Tokado H, Fukuzaki K, Nagata R, et al. Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates. J Pharmacol Sci 2008; 107: 32-40.
56. Bu Y, Jin ZH, Park SY, Baek S, Rho S, Ha N, et al. Siberian ginseng reduces infarct volume in transient focal cerebral ischaemia in Sprague-Dawley rats. Phytother Res 2005; 19: 167-169.
57. Zhu XL, Zhang N, Li PT, Jiang YF, Xu Y. [Protective effect of jasminoidin on cascade of damage of cerebral ischemia in rats]. Zhongguo Zhong Yao Za Zhi 2004; 29: 1065-1068.
58. Zhang ZJ, Li P, Wang Z, Li PT, Zhang WS, Sun ZH, et al. A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res 2006; 1123: 188-195.
59. Zhang CY, Du GY, Wang W, Ye ZG, Wang DQ, Sun XF, et al. [Effects of tianma gouteng fang on transmitter amino acids in the hippocampus extracellular liquids in freely moving rats subjected to brain ischemia]. Zhongguo Zhong Yao Za Zhi 2004; 29: 1061-1065.
60. Yokoyama K, Shimada Y, Hori E, Nakagawa T, Takagi S, Sekiya N, et al. Effects of Choto-san and hooks and stems of Uncaria sinensis on antioxidant enzyme activities in the gerbil brain after transient forebrain ischemia. J Ethnopharmacol 2004; 95: 335-343.
61. Pero RW, Amiri A, Sheng Y, Welther M, Rich M. Formulation and in vitro/in vivo evaluation of combining DNA repair and immune enhancing nutritional supplements. Phytomedicine 2005; 12: 255-263.
62. Na M, Kim YH, Min BS, Bae K, Kamiryo Y, Senoo Y, et al. Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Uncaria sinensis Havil. J Ethnopharmacol 2004; 95: 127-132.
63. Sun F, Liu TP. Tetrandrine vs nicardipine in cerebral ischemia-reperfusion damages in gerbils. Zhongguo Yao Li Xue Bao 1995; 16: 145-148.
64. Liu SJ, Zhou SW, Xue CS. Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion. Acta Pharmacol Sin 2001; 22: 971-975.
65. Yu XQ, Xue CC, Zhou ZW, Li CG, Zhou SF. Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts neuroprotective effect via inhibition of neuronal apoptosis in vitro. Phytother Res 2008; 22: 846-850.
66. Dong Y, Liu HD, Zhao R, Yang CZ, Chen XQ, Wang XH, et al. Ischemia activates JNK/c-Jun/ AP-1 pathway to up-regulate 14-3-3gamma in astrocyte. J Neurochem 2009; 109 Suppl 1: 182-188.
67. Luo Z, Liu S, Yuan G. [Effects of zuzhongping on ischemic volume in the rat model of middle cerebral artery occlusion]. Hua Xi Yi Ke Da Xue Xue Bao 1994; 25: 103-104.
68. Xuejiang W, Magara T, Konishi T. Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats. Free Radic Res 1999; 31: 449-455.
69. Ichikawa H, Wang X, Konishi T. Role of component herbs in antioxidant activity of shengmai san-a traditional Chinese medicine formula preventing cerebral oxidative damage in rat. Am J Chin Med 2003; 31: 509-521.
70. Wang NL, Chang CK, Liou YL, Lin CL, Lin MT. Shengmai San, a Chinese herbal medicine protects against rat heat stroke by reducing inflammatory cytokines and nitric oxide formation. J Pharmacol Sci 2005; 98: 1-7.
71. Konishi T. Brain oxidative stress as basic target of antioxidant traditional oriental medicines. Neurochem Res 2009 Apr; 34: 711-716.
72. Yao HT, Chang YW, Chen CT, Chiang MT, Chang L, Yeh TK. Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet. J Ethnopharmacol 2008; 116: 49-57.
73. Nishida H, Ichikawa H, Konishi T. Shengmai-san enhances antioxidant potential in C2C12 myoblasts through the induction of intracellular glutathione peroxidase. J Pharmacol Sci 2007; 105: 342-352.
74. Jingyi W, Yasuhiro M, Naoya H, Seok RC, Yoshiharu Y, Nagara T, et al. Observation on the effects of Chinese medicine zhenxuanyin for improving cerebral blood flow in rats with cerebral ischemia. J Tradit Chin Med 1997; 17: 299-303.
75. Tripathi YB, Tripathi P, Korlagunta K, Chai SC, Smith BJ, Arjmandi BH. Role of Sandhika: a polyherbal formulation on MC3T3-E1 osteoblast-like cells. Inflammation 2008; 31: 1-8.
76. Tripathi YB. BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 49-57.
77. Tripathi YB, Reddy MM, Pandey RS, Subhashini J, Tiwari OP, Singh BK, et al. Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis. Inflammopharmacology 2004; 12: 131-152.
78. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP. Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian J Exp Biol 1996; 34: 523-526.
79. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 2002; 16: 639-645.
80. Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol 2008; 120: 112-127.
81. Deb DD, Kapoor P, Dighe RP, Padmaja R, Anand MS, D'Souza P, et al. In vitro safety evaluation and anticlastogenic effect of BacoMind on human lymphocytes. Biomed Environ Sci 2008; 21: 7-23.
82. Tripathi YB, Tripathi E, Upadhyay A. Antilipid peroxidative property of Nardostachys jatamanasi. Indian J Exp Biol 1996; 34: 1150-1151.
83. Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food 2006 Spring; 9: 113-138.
84. Lyle N, Gomes A, Sur T, Munshi S, Paul S, Chatterjee S, et al. The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behav Brain Res 2009; 202: 285-290.
85. Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol 1998; 60: 173-178.
86. Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P, et al. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 2004; 260: 39-47.
87. Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, Gupta SK. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 2004; 94: 184-190.
88. Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease. Neurosci Lett 2009; 454: 11-15.
89. Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 2000; 7: 427-448.
90. Biswas TK, Mukherjee B. Plant medicines of Indian origin for wound healing activity: a review. Int J Low Extrem Wounds 2003; 2: 25-39.
91. Guo JS, Cheng CL, Koo MW. Inhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med 2004; 70: 1150-1154.
92. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet 2000; 355(9219): 1949-1954.
93. Gnanapragasam A, Ebenezar KK, Sathish V, Govindaraju P, Devaki T. Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats. Life Sci 2004; 76: 585-597.
94. Joy J, Nair CK. Protection of DNA and membranes from gamma-radiation induced damages by Centella asiatica. J Pharm Pharmacol 2009; 61: 941-947.
95. Krishnamurthy RG, Senut MC, Zemke D, Min J, Frenkel MB, Greenberg EJ, et al. Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J Neurosci Res 2009; 87: 2541-2450.
96. Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, et al. Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother Res 2009; 23: 14-19.
97. Subban R, Veerakumar A, Manimaran R, Hashim KM, Balachandran I. Two new flavonoids from Centella asiatica (Linn.). J Nat Med 2008; 62: 369-373.
98. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res 2007; 21: 401-405.
99. Ghosal S, Reddy JP, Lal VK. Shilajit I: chemical constituents. J Pharm Sci 1976; 65: 772-773.
100. Goel RK, Banerjee RS, Acharya SB. Antiulcerogenic and antiinflammatory studies with shilajit. J Ethnopharmacol 1990; 29: 95-103.
101. Acharya SB, Frotan MH, Goel RK, Tripathi SK, Das PK. Pharmacological actions of Shilajit. Indian J Exp Biol 1988; 26: 775-777.
102. Rawal A, Muddeshwar M, Biswas S. Effect of Rubia cordifolia, Fagonia cretica linn, and Tinospora cordifolia on free radical generation and lipid peroxidation during oxygen-glucose deprivation in rat hippocampal slices. Biochem Biophys Res Commun 2004; 324: 588-596.
103. Leyon PV, Kuttan G. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. Int Immunopharmacol 2004; 4: 1569-1575.
104. Singh RP, Banerjee S, Kumar PV, Raveesha KA, Rao AR. Tinospora cordifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 2006; 13: 74-84.
105. Reddy SS, Ramatholisamma P, Karuna R, Saralakumari D. Preventive effect of Tinospora cordifolia against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats. Food Chem Toxicol 2009; 47: 2224-2229.
106. Sengupta S, Mukherjee A, Goswami R, Basu S. Hypoglycemic activity of the antioxidant saponarin, characterized as alpha-glucosidase inhibitor present in Tinospora cordifolia. J Enzyme Inhib Med Chem 2008; 1.
107. Sairam K, Rao CV, Goel RK. Effect of Convolvulus pluricaulis Chois on gastric ulceration and secretion in rats. Indian J Exp Biol 2001; 39: 350-354.
108. Panda S, Kar A. Inhibition of T3 production in levothyroxine-treated female mice by the root extract of Convolvulus pluricaulis. Horm Metab Res 2001; 33: 16-18.
109. Bihaqi SW, Sharma M, Singh AP, Tiwari M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol 2009; 124: 409-415.
110. Sreejayan, Rao MN. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994; 46: 1013-1016.
111. Rajakumar DV, Rao MN. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem 1994; 140: 73-79.
112. Zhao J, Zhao Y, Zheng W, Lu Y, Feng G, Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 2008; 1229: 224-232.
113. Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC. Anti-ischemic effect of curcumin in rat brain. Neurochem Res 2008; 33: 1036-1043.
114. Mediratta PK, Tanwar K, Reeta KH, Mathur R, Benerjee BD, Singh S, et al. Attenuation of the effect of lindane on immune responses and oxidative stress by Ocimum sanctum seed oil (OSSO) in rats. Indian J Physiol Pharmacol 2008; 52: 171-177.
115. Shetty S, Udupa S, Udupa L. Evaluation of Antioxidant and Wound Healing Effects of Alcoholic and Aqueous Extract of Ocimum sanctum Linn in Rats. Evid Based Complement Alternat Med 2008; 5: 95-101.
116. Manikandan P, Vidjaya Letchoumy P, Prathiba D, Nagini S. Combinatorial chemopreventive effect of Azadirachta indica and Ocimum sanctum on oxidant-antioxidant status, cell proliferation, apoptosis and angiogenesis in a rat forestomach carcinogenesis model. Singapore Med J 2008; 49: 814-822.
117. Jyoti S, Satendra S, Sushma S, Anjana T, Shashi S. Antistressor activity of Ocimum sanctum (Tulsi) against experimentally induced oxidative stress in rabbits. Methods Find Exp Clin Pharmacol 2007; 29: 411-416.
118. Halder N, Joshi S, Nag TC, Tandon R, Gupta SK. Ocimum sanctum extracts attenuate hydrogen peroxide induced cytotoxic ultrastructural changes in human lens epithelial cells. Phytother Res 2009.
119. Aguilera P, Chanez-Cardenas ME, Ortiz-Plata A, Leon-Aparicio D, Barrera D, Espinoza-Rojo M, et al. Aged garlic extract delays the appearance of infarct area in a cerebral ischemia model, an effect likely conditioned by the cellular antioxidant systems. Phytomedicine 2009.
120. Rai SK, Sharma M, Tiwari M. Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. Life Sci 2009; 85: 211-219.
121. Das Gupta A, Dhara PC, Dhundasi SA, Das KK. Effect of garlic (Allium sativum) on nickel II or chromium VI induced alterations of glucose homeostasis and hepatic antioxidant status under sub-chronic exposure conditions. J Basic Clin Physiol Pharmacol 2009; 20: 1-14.
122. Lii CK, Chen HW, Yun WT, Liu KL. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264. 7 macrophages. J Ethnopharmacol 2009; 122: 227-233.
123. Teoh SL, Latiff AA, Das S. The effect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin. Clin Exp Dermatol 2009; 34: 815-822.
124. Deng R. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev 2007 Winter; 25: 375-390.
125. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 2007; 7: 344-351.
126. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994; 8: 659-664.
127. Shah ZA, Gilani RA, Sharma P, Vohora SB. Cerebroprotective effect of Korean ginseng tea against global and focal models of ischemia in rats. J Ethnopharmacol 2005; 101: 299-307.
128. Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 2008; 10: 1255-1263.
129. Zhang DL, Zhang YT, Yin JJ, Zhao BL. Oral administration of Crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils. J Neurochem 2004; 90: 211-219.
130. Zhao B. Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 2005; 31: 283-293.
131. Li L, Shen YM, Yang XS, Wu WL, Wang BG, Chen ZH, et al. Effects of spiramine T on antioxidant enzymatic activities and nitric oxide production in cerebral ischemia-reperfusion gerbils. Brain Res 2002; 944: 205-209
132. Li L, Nie J, Shen Z, Wu W, Chen Z, Hao X. Neuroprotective effects in gerbils of spiramine T from Spiraea japonica var. acuta. Planta Med 2001; 67: 142-145.